Is BRN 5365754 Safe in Breastfeeding

I am a breastfeeding mother and i want to know if it is safe to use BRN 5365754? Is BRN 5365754 safe for nursing mother and child? Does BRN 5365754 extracts into breast milk? Does BRN 5365754 has any long term or short term side effects on infants? Can BRN 5365754 influence milk supply or can BRN 5365754 decrease milk supply in lactating mothers?

• DrLact safety Score for BRN 5365754 is 5 out of 8 which is considered Unsafe as per our analyses.
• A safety Score of 5 indicates that usage of BRN 5365754 may cause serious side effects in breastfed baby.
• Our study of different scientific research indicates that BRN 5365754 may cause moderate to high side effects or may affect milk supply in lactating mother.
• Our suggestion is to use safer alternate options rather than using BRN 5365754 .
• It is recommended to evaluate the advantage of not breastfeeding while using BRN 5365754 Vs not using BRN 5365754 And continue breastfeeding.
• While using BRN 5365754 Its must to monitor child for possible reactions. It is also important to understand that side effects vary largely based on age of breastfed child and time of medication in addition to dosage.
• Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.

Sulfonilurea drugs stimulate secretion of endogen insulin. Oral anti-diabetic drugs are useless for treatment of diabetes type 1. For diabetes type 2, diet and exercise are advisable. Breastfeeding helps to lower glucemia level. See section on Maternal diabetes mellitus

Because no information is available on the use of BRN 5365754 during breastfeeding, an alternate drug may be preferred, especially while nursing a newborn or preterm infant. Monitor breastfed infants for signs of hypoglycemia such as jitteriness, excessive sleepiness, poor feeding, seizures cyanosis, apnea, or hypothermia. If there is concern, monitoring of the breastfed infant's blood glucose is advisable during maternal therapy with BRN 5365754.[1][2]